chr12-565381-C-T
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong
The NM_016533.6(NINJ2):c.283G>A(p.Val95Ile) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000396 in 1,614,138 control chromosomes in the GnomAD database, including 1 homozygotes. In-silico tool predicts a benign outcome for this variant. 13/19 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. V95A) has been classified as Uncertain significance.
Frequency
Consequence
NM_016533.6 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
NINJ2 | NM_016533.6 | c.283G>A | p.Val95Ile | missense_variant | 3/4 | ENST00000305108.10 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
NINJ2 | ENST00000305108.10 | c.283G>A | p.Val95Ile | missense_variant | 3/4 | 1 | NM_016533.6 | P1 |
Frequencies
GnomAD3 genomes AF: 0.000217 AC: 33AN: 152212Hom.: 0 Cov.: 33
GnomAD3 exomes AF: 0.000267 AC: 67AN: 251314Hom.: 0 AF XY: 0.000228 AC XY: 31AN XY: 135852
GnomAD4 exome AF: 0.000415 AC: 606AN: 1461808Hom.: 1 Cov.: 31 AF XY: 0.000424 AC XY: 308AN XY: 727206
GnomAD4 genome AF: 0.000217 AC: 33AN: 152330Hom.: 0 Cov.: 33 AF XY: 0.000175 AC XY: 13AN XY: 74482
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Jan 30, 2024 | The c.421G>A (p.V141I) alteration is located in exon 3 (coding exon 3) of the NINJ2 gene. This alteration results from a G to A substitution at nucleotide position 421, causing the valine (V) at amino acid position 141 to be replaced by an isoleucine (I). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at